- Corporate Officers - D
- Drapeau Louis
Insider Trading History of Drapeau Louis
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Drapeau Louis since 2006.
The trader's CIK number is 1248091.
At the time of the last reporting, Drapeau Louis was the VP, Chief Financial of Armata Pharmaceuticals, Inc.. (stock ticker symbol ARMP).
Also see all insider trading activities at Armata Pharmaceuticals, Inc..
Note that in the past
DRAPEAU LOUIS also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Bionovo Inc (BNVI) by Drapeau Louis
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | BNVI | 10,000 | $9,700 | 0 | $0 | 0 | $0 |
| 2008 | BNVI | 30,000 | $11,010 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Armata Pharmaceuticals, Inc. (APHB) by Drapeau Louis
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | APHB | 10,000 | $43,900 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Insite Vision Inc (INSV) by Drapeau Louis
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | INSV | 200,000 | $120,000 | 0 | $0 | 0 | $0 |
| 2008 | INSV | 10,000 | $7,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Drapeau Louis
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | NKTR | 1,000 | $11,770 | 0 | $0 | 0 | $0 |
| 2006 | NKTR | 4,000 | $71,430 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Intermune Inc (ITMN) by Drapeau Louis
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ITMN | 0 | $0 | 0 | $0 | 3,000 | $0 |
| 2008 | ITMN | 1,000 | $17,450 | 0 | $0 | 0 | $0 |
| 2007 | ITMN | 1,000 | $16,810 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Drapeau Louis:
1. Bionovo Inc (BNVI)
2. Armata Pharmaceuticals, Inc. (APHB)
3. Insite Vision Inc (INSV)
4. Nektar Therapeutics (NKTR)
5. Intermune Inc (ITMN)
Table 1. Insider trading of Bionovo Inc (BNVI) by Drapeau Louis
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-10-19 | BNVI | Buy | 10,000 | .97 | 9,700 |
| 2008-11-28 | BNVI | Buy | 13,000 | .35 | 4,550 |
| 2008-12-01 | BNVI | Buy | 17,000 | .38 | 6,460 |
Table 2. Insider trading of Armata Pharmaceuticals, Inc. (APHB) by Drapeau Louis
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-10-06 | APHB | Buy | 10,000 | 4.39 | 43,900 |
Table 3. Insider trading of Insite Vision Inc (INSV) by Drapeau Louis
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-07-18 | INSV | Buy | 200,000 | .60 | 120,000 |
| 2008-02-29 | ISV | Buy | 10,000 | .78 | 7,800 |
Table 4. Insider trading of Nektar Therapeutics (NKTR) by Drapeau Louis
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-03-05 | NKTR | Buy | 1,000 | 11.77 | 11,770 |
| 2006-11-07 | NKTR | Buy | 1,000 | 14.65 | 14,650 |
| 2006-08-08 | NKTR | Buy | 1,000 | 16.35 | 16,350 |
| 2006-05-15 | NKTR | Buy | 1,000 | 20.35 | 20,350 |
| 2006-03-03 | NKTR | Buy | 1,000 | 20.08 | 20,080 |
Table 5. Insider trading of Intermune Inc (ITMN) by Drapeau Louis
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-05-30 | ITMN | Option Ex | 3,000 | .00 | 0 |
| 2008-08-06 | ITMN | Buy | 1,000 | 17.45 | 17,450 |
| 2007-11-08 | ITMN | Buy | 1,000 | 16.81 | 16,810 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Drapeau Louis
(VP, Chief Financial of Armata Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.